Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Up to 40% of patients not taking their blood pressure tablets as prescribed

Prevalence of non-adherence is widespread, and increases with the number of blood pressure drugs prescribed per patient.

multiple medications to treat high blood pressure


Non-adherence to antihypertensive medications is linked to the number of drugs prescribed, with non-adherence risk increased by 85% with each extra drug prescribed.

Non-adherence to antihypertensive treatment is common in the United Kingdom and Czech Republic, according to a new study. 

Researchers analysed urine samples from 1,400 patients to reveal whether they were taking their antihypertensive drugs as prescribed, and found that non-adherence for UK patients was 41.6% and 31.5% in the Czech Republic cohort. 

They also found that non-adherence was linked to the number of hypertensive medicines prescribed. Non-adherence risk increased by 85% with each additional drug in the UK cohort and by 77% in Czech Republic patients (P <0.001). 

Writing in the latest edition of the journal Hypertension[1] (June 2017), they say: “Although non-adherence among those who were prescribed only one antihypertensive was minimal, the majority (79.3%) of UK patients prescribed ≥6 BP-lowering medications were non-adherent to antihypertensive treatment.” 

They also discovered that 14.5% of the UK patients took none of their prescribed medicines compared to 12% of the Czech Republic patients. 

In the 676 UK-patient cohort the rates of any, partial, and total non-adherence were 41.6%, 27.1%, and 14.5%, respectively. And out of the 2,562 drugs prescribed to them 815 (31.8%) were not detected in the urine sample. 

The prevalence of any, partial, and total non-adherence was 31.5%, 19.5%, and 12.1%, respectively, among the 672 Czech Republic patients. The overall percentage of prescribed antihypertensive medications undetected was 24.1%. 

Younger patients and women were more likely not to take their hypertensive medications compared to any other groups of patients, they found. 

The findings were based on the results of urine samples at the National Centre for Adherence Testing (NCAT) established by the University Hospitals of Leicester. 

The researchers say their data reveal a widespread prevalence of non-adherence, irrespective of the country or region of recruitment. 

“We show that both the number and the class of prescribed antihypertensives are strong independent risk factors for biochemically confirmed non-adherence to antihypertensive treatment.” 

They add: “Further development of discriminatory models incorporating these parameters might prove clinically useful in assessment of non-adherence in countries where biochemical analysis is unavailable.” 

Prashanth Patel, lead researcher, told The Pharmaceutical Journal that he thinks the urine test is too technical to be routinely offered by community pharmacists and is also expensive — the equipment costs around £500,000. 

He also thinks that the cost of prescriptions might be a factor in non-adherence, because costs go up each time a UK patient is prescribed another hypertensive drug. 

Commenting on the study, Sotiris Antoniou, consultant pharmacist, cardiovascular medicine at Barts Health NHS Trust, says that the use of a urine test to assess adherence is becoming more widespread in clinical practice especially for patients taking multiple drugs for uncontrolled blood pressure. 

He says: “The study findings, like others, show that the number of medications prescribed is inversely proportional to adherence. This may be due to the pill burden or the increased likelihood of experiencing a side effect with more medicines and the difficulty for the individual to associate the side effect with an individual medicine and hence stopping all medicines.” 

He says that community pharmacists can support patients with their medication and this study “supports the need for appropriate questioning when an additional agent has been added for the management of blood pressure through the use of enablers such as the New Medicines Service as to whether the individual has experienced any difficulty or complications with their current therapy to identify whether non-adherence is a potential cause of uncontrolled blood pressure.”

Mahendra Patel, a member of the Royal Pharmaceutical Society English Pharmacy Board

Source: MAG / The Pharmaceutical Journal

Mahendra Patel, a member of the Royal Pharmaceutical Society English Pharmacy Board, who was also a member of the NICE guideline development group on medicines adherence, says: “While the non-adherence figures are high, hypertension is asymptomatic and often people may not understand the full value and importance of taking their medicines.

He adds: “The patient demographic is also important. In black minority ethnic groups this non-adherence figure could potentially be much higher.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202883

Readers' comments (2)

  • Having carried out hundreds of Murs in a variety of settings ,this paper does not reflect my experience .Patients are not always happy to take medication but they know it's in their best interest.

    Unsuitable or offensive? Report this comment

  • Is to possible that these patients were poorly compliant when they were only taking one medicine, therefore their BP was poorly controlled so more meds kept being added without anyone asking the question, "are you taking what you have been prescribed?"

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £47.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • multiple medications to treat high blood pressure

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.